SMTL ID : 6x8e.1 (1 other biounit)

Crystal structure of JAK2 with Compound 11

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.75 Å

Oligo State

monomer

Ligands

1 x UWP: [3-{4-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]-1H-pyrazol-1-yl}-1-(2,2,2-trifluoroethyl)azetidin-3-yl]acetonitrile(Non-covalent)

UWP.1: 22 residues within 4Å: Chain A: L.21, G.22, K.23, G.24, G.27, S.28, V.29, A.46, K.48, V.77, M.95, E.96, Y.97, L.98, P.99, Y.100, G.101, R.146, N.147, L.149, G.159, D.160 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.21, A:L.149, A:L.149 Hydrogen bonds: A:L.98 Water bridges: A:K.23, A:S.102 Salt bridges: A:D.160

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gerstenberger, B.S. et al., Discovery of Tyrosine Kinase 2 (TYK2) Inhibitor (PF-06826647) for the Treatment of Autoimmune Diseases. J.Med.Chem. (2020)

Release Date

2020-11-25

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence